why choose us

First received: December 12, 2022

Clinical Trial: A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Crohn Disease

Study Type: INTERVENTIONAL


Official Title: A 44-Week Phase 2b Long-Term Extension, RandomizEd, Double-BLind, Study to Determine the Long-Term PharmacokInetics, Efficacy, Safety, and Tolerability of TEV-48574 in Adult PatiEnts With Moderate to

Brief Summary: The primary objective of the study is to evaluate the efficacy and dose response of 2 different maintenance dose regimens of TEV-48574 subcutaneous (sc) administered every 4 weeks (Q4W) in adult participants with inflammatory bowel disease (IBD).Secondary objectives of the study are to:evaluate the efficacy of 2 different maintenance dose regimens of TEV-48574 sc administered Q4W in adult participants with IBDevaluate the safety and tolerability of 2 different maintenance dose regimens of TEV-48574 sc administered…

Read more